InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Shook David. Director active across 2 companies, notably Nkarta, Inc.. Cumulatively, 12 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €59k. Activity tracked since 13 January 2023. The latest transaction was filed on 10 September 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Shook David is Chief Medical Officer at Lyell Immunopharma, Inc. He has 11 filings in total, and across the 11 sampled filings the transactions run from 2023-01-18 to 2025-06-11, with EUR 0 of buys and EUR 53,362 of sells, mainly related to Nkarta, Inc.